SHH is critical in the activation of GBM cancer stem cells, and inhibition of the SHH signaling pathway eliminates GBM tumorigenicity while also increasing the sensitivity of GBM patients to radiotherapy and concomitant and adjuvant TMZ15,16. This evidence concerns the gene SHH and cancer.